MBX Stock: Price, Earnings History and SEC Filings
MBX Biosciences, Inc. (MBX) last traded at $55.87, up 2.44% on the latest session and down 4.7% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.78 against an analyst estimate of $-0.68, a miss of 14.7%.
$55.87 +2.44%
1 month-4.69%
52-week high$72.64
52-week low$20.21
Volume667,266
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
MBX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-0.78 | $-0.68 | -14.71% |
| Mar 2026 | May 7, 2026 | $-0.51 | $-0.62 | +17.74% |
| Dec 2025 | Mar 12, 2026 | $-0.49 | $-0.64 | +23.44% |
| Sep 2025 | Nov 6, 2025 | $-0.63 | $-0.73 | +13.70% |
MBX beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for MBX
SEC filing data is not available right now. You can search for MBX on SEC EDGAR.
MBX news
- MBX Biosciences Names Peter Radovich as Independent Class I DirectorOct 22, 2026 · kalkinemedia.com
About MBX Biosciences, Inc.
MBX Biosciences, Inc. (MBX) is a US-listed public company on Nasdaq.